Consistent with what was provided at the J.P. Morgan Conference a few weeks ago, we expect 2026 R&D spend to be in the range of $5.9 to $6.1 billion. The increase versus 2025 is driven by costs to support our expanding late-stage pipeline, including new Phase III studies in oncology and hemat, our Factor XI antibodies, and our obesity program.
Jan 30, 2026 / receipt
Consistent with what was provided at the J.P. Morgan Conference a few weeks ago, we expect 2026 R&D spend to be in the range of $5.9 to $6.1 billion. The increase versus 2025 is driven by costs to support our expanding late-stage pipeline, including new Phase III studies in oncology and hemat, our Factor XI antibodies, and our obesity program.
Jan 30, 2026 / receipt, needs a key / Chris, CFO | earnings call 2026-01-30 | transcript 130db652-0833-4325-8cfa-3a8b8bfbf8f8 | chars 30950-31295 | segment 30
Starting with R&D expense in 2024, which is anticipated to be in the range of $4.3 to $4.5 billion, as George just discussed and as we highlighted at the JPMorgan conference, our pipeline continues to expand with a growing number of registration-enabling studies ongoing, are expected to initiate this year.
Feb 2, 2024 / receipt, needs a key / George Yancopoulos, other | earnings call 2024-02-02 | transcript c17595ca-468d-4dfd-97f1-b4d5cb729ba9 | chars 30973-31280 | segment 31
However, we recently were informed that an FDA travel complication relating to scheduling a routine clinical trial site inspection in Eastern Europe will likely delay their decision until after our September 19th PDUFA date.
Aug 3, 2022 / receipt, needs a key / Bob Landry, CFO | earnings call 2022-08-03 | transcript d2460f26-35af-4e81-9594-2ef6fc22821c | chars 7472-7696 | segment 7
Director Market Access | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Amsterdam3/Director-Market-Access_R50646", "remote": false, "category": "other", "function": "other", "location
company_statement / Sep 16, 2026 / receipt
Director, Regional Market Access Lead - Europe | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Dublin/Director--Regional-Market-Access-Lead---Europe_R50547", "remote": false, "catego
company_statement / Sep 16, 2026 / receipt
Principal Data Engineer | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Limerick/Principal--Data-Engineer_R43097", "remote": false, "category": "other", "function": "data", "location
company_statement / Sep 16, 2026 / receipt
Director Market Access | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Munich/Director-Market-Access_R50648", "remote": false, "category": "other", "function": "other", "location": "
company_statement / Sep 16, 2026 / receipt
Director Market Access | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Paris/Director-Market-Access_R50647", "remote": false, "category": "other", "function": "other", "location": "P
company_statement / Sep 16, 2026 / receipt
Medical Specialist I-Pulmonology-Pittsburgh, PA | {"ats": "workday", "city": "Pittsburgh", "state": "PA", "job_id": "/job/Pittsburgh-PA/Medical-Specialist-I-Pulmonology-Pittsburgh--PA_R50475", "remote
company_statement / Sep 16, 2026 / receipt
Delegado(a) de ventas - Baleares, Barcelona, Gerona y Lerida | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Remote---Spain/Delegado-a--de-ventas---Baleares--Barcelona--Gerona-y-Leri
company_statement / Sep 16, 2026 / receipt
Scientist, Cardiac Vascular - In Vivo | {"ats": "workday", "city": null, "state": null, "job_id": "/job/TARRYTOWN/Scientist--Cardiac-Vascular---In-Vivo_R49817", "remote": false, "category": "other", "
company_statement / Sep 16, 2026 / receipt
Director Integrated Data Quality | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Warren/Director-Integrated-Data-Quality_R50031", "remote": false, "category": "other", "function": "o
company_statement / Sep 16, 2026 / receipt
Director Market Access | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Dublin/Director-Market-Access_R50435", "remote": false, "category": "other", "function": "other", "location": "
company_statement / Sep 15, 2026 / receipt
Payroll Service Delivery Analyst (International) | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Hyderabad/Payroll-Service-Delivery-Analyst--International-_R50458", "remote": false,
company_statement / Sep 15, 2026 / receipt
Payroll Service Delivery Analyst (US)-1 | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Hyderabad/Payroll-Service-Delivery-Analyst--US--1_R50454", "remote": false, "category": "finan
company_statement / Sep 15, 2026 / receipt
| Bob Dean | CFO | - | receipt |
| Bob Landry | CFO | - | receipt |
| Christopher Fenimore | Senior Vice President | - | receipt |
| Dr. George Yancopoulos | CSO | - | receipt |
| Dr. Leonard Schleifer | CEO | - | receipt |
| Jason Pitofsky | Senior Vice President, Controller | - | receipt |
| 2026-10-30 | earnings call | scheduled | ir |
| 2024-01-31 | Senior Vice President, appointed | sec_8k |
| 2024-01-31 | Vice President, appointed | sec_8k |
| 2023-09-08 | Executive Vice President, retiring | sec_8k |
| 2018-01-02 | Executive Vice President, departed | sec_8k |